8-K/A filed October 9, 2024, 7:59 PM ET CIK 0001708331

leadership confidence high sentiment negative materiality 0.80

Virpax CEO & CFO resign amid disagreements; Nasdaq warns of bid price deficiency

Virpax Pharmaceuticals, Inc.

CEO Gerald Bruce and CFO Vinay Shah resigned Oct 5, citing disagreements with Board's execution of policies.
Board appointed director Jatinder Dhaliwal as new CEO effective Oct 6; Katharyn Field replaces him on audit committee.
Nasdaq notified company Oct 4 that bid price below $1.00 for 30 consecutive days; 180-day cure period until Apr 2, 2025.
Company disagrees with allegations in Bruce's resignation letter, filed as exhibit.
If not compliant by Apr 2, 2025, may get second 180-day period; delisting risk if not cured.

item 3.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jatinder Dhaliwal

Chief Executive Officer

Virpax Pharmaceuticals, Inc.

Effective: 2024-10-06
Filed: October 9, 2024, 7:59 PM ET

On October 6, 2024, the Board appointed Jatinder Dhaliwal, a member of the Board, to serve as Chief Executive Officer of the Company, effective immediately.

Departed

Gerald Bruce

Chief Executive Officer

Virpax Pharmaceuticals, Inc.

Effective: 2024-10-05
Successor: Jatinder Dhaliwal
Filed: October 9, 2024, 7:59 PM ET

On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.

Departed

Gerald Bruce

Director

Virpax Pharmaceuticals, Inc.

Effective: 2024-10-05
Filed: October 9, 2024, 7:59 PM ET

On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.

Departed

Vinay Shah

Chief Financial Officer

Virpax Pharmaceuticals, Inc.

Effective: 2024-10-05
Filed: October 9, 2024, 7:59 PM ET

On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jatinder Dhaliwal was appointed as Chief Executive Officer at Virpax Pharmaceuticals, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On October 6, 2024, the Board appointed Jatinder Dhaliwal, a member of the Board, to serve as Chief Executive Officer of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gerald Bruce resigned as Chief Executive Officer at Virpax Pharmaceuticals, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gerald Bruce resigned as Director at Virpax Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Vinay Shah resigned as Chief Financial Officer at Virpax Pharmaceuticals, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001731122-24-001573

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.